Non-small cell lung cancer metastatic Trials in Strasbourg, France
Conditions / Non-small cell lung cancer metastatic / Strasbourg, France
Non-small cell lung cancer metastatic has been the subject of sustained clinical investigation across multiple research sites.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05117242 | Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung Cancer | ACTIVE_NOT_RECRUITING | — |
| NCT07420439 | Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease | NOT_YET_RECRUITING | — |
| NCT03956641 | Evolution of the Physical Condition in Treated Cancer Patients | UNKNOWN | NA |
| NCT03774732 | PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03977194 | Atezolizumab in Elderly Patients With Advanced Non-Small-Cell Lung Cancer and Receiving Carboplatin Paclitaxel Chemotherapy | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01798485 | A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC | TERMINATED | PHASE3 |
| NCT02162537 | Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases | TERMINATED | PHASE3 |
| NCT02117167 | SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC Patients | COMPLETED | PHASE2 |
| NCT03304093 | Immunotherapy by Nivolumab for HIV+ Patients | COMPLETED | PHASE2 |
| NCT04233021 | Study of Osimertinib in Patients with a Lung Cancer with Brain or Leptomeningeal Metastases with EGFR Mutation | COMPLETED | PHASE2 |